Global 24-Hours Phase I Operations
In 2008 START expanded globally with the opening of START Madrid. This was the first step in our goal to keep the development of anticancer agents operating 24 hours a day. In 2011, we opened START Shanghai. In 2013, we opened our second site in START Madrid FJD. Our most recent site to open was in 2015 when we opened our second US location in Grand Rapids with START Midwest.
In 2016, with centers located on three continents –– two in the US, two in Spain and one in China –– START conducts the world’s largest Phase I medical oncology program and is bringing new hope to patients who otherwise would not have access to these promising new therapies.
Learn more about START’s dedicated, round-the-clock network of START Centers dedicated to Phase I cancer clinical trials.